Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hayes

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Nature Genetics|December 25, 2007
Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous culturesDaniela Delneri, David C Hoyle, Konstantinos Gkargkas, et al.
FEBS Open Bio|June 5, 2026
Molecular characterization of covRS mutations in M1<sub>UK</sub> Streptococcus pyogenesJarrad Pritchard, Emma-Jayne Proctor, Jiawa Wang, et al.
Anticancer Research|September 15, 2019
The Role of Local Therapy in Multi-focal Epithelioid HaemangioendotheliomaDaniel Tong, Anastasia Constantinidou, Bodil Engelmann, et al.
Frontiers in Immunology|March 23, 2023
Characterization of a mutant <i>samhd1</i> zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutières syndromeSarah E Withers, Charlie F Rowlands, Victor S Tapia, et al.
Cancer Discovery|December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Science Signaling|March 27, 2014
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signalingBerta Sanchez-Laorden, Amaya Viros, Maria Romina Girotti, et al.
The Oncologist|September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid TumorsSpyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
Frontiers in Oncology|May 21, 2019
Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With HistopathologyJessica M Winfield, Aisha B Miah, Dirk Strauss, et al.
Arthritis Research & Therapy|June 16, 2019
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profilesJohn A Reynolds, Tracy A Briggs, Gillian I Rice, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Nature Genetics|December 25, 2007
Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous culturesDaniela Delneri, David C Hoyle, Konstantinos Gkargkas, et al.
FEBS Open Bio|June 5, 2026
Molecular characterization of covRS mutations in M1<sub>UK</sub> Streptococcus pyogenesJarrad Pritchard, Emma-Jayne Proctor, Jiawa Wang, et al.
Anticancer Research|September 15, 2019
The Role of Local Therapy in Multi-focal Epithelioid HaemangioendotheliomaDaniel Tong, Anastasia Constantinidou, Bodil Engelmann, et al.
Frontiers in Immunology|March 23, 2023
Characterization of a mutant <i>samhd1</i> zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutières syndromeSarah E Withers, Charlie F Rowlands, Victor S Tapia, et al.
Cancer Discovery|December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaMaria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
Science Signaling|March 27, 2014
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signalingBerta Sanchez-Laorden, Amaya Viros, Maria Romina Girotti, et al.
The Oncologist|September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid TumorsSpyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
Frontiers in Oncology|May 21, 2019
Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With HistopathologyJessica M Winfield, Aisha B Miah, Dirk Strauss, et al.
Arthritis Research & Therapy|June 16, 2019
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profilesJohn A Reynolds, Tracy A Briggs, Gillian I Rice, et al.
Pageof 9